Evidence map›Paper›PMID 34227364›Full record

ReviewSe pu = Chinese journal of chromatography2021

[Applications of separation technology in novel coronavirus research, epidemic prevention and detection].

Linsen Li, Chao Zhu, Xinying Zhao, Feng Qu

Open access · hybridAbstract readReview
In one paragraph

Review in Se pu = Chinese journal of chromatography, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Linsen LiSchool of Life Science, Beijing Institute of Technology, "Molecular Medicine and Biological Diagnosis" Key Laboratory of Ministry of Industry and Information Technology, Beijing 100081, China.
Chao ZhuSchool of Life Science, Beijing Institute of Technology, "Molecular Medicine and Biological Diagnosis" Key Laboratory of Ministry of Industry and Information Technology, Beijing 100081, China.
Xinying ZhaoBeijing Polytechnic, Beijing 100176, China.
Feng QuSchool of Life Science, Beijing Institute of Technology, "Molecular Medicine and Biological Diagnosis" Key Laboratory of Ministry of Industry and Information Technology, Beijing 100081, China.
Beijing Institute of Technology · CNBeijing Polytechnic · CNMinistry of Industry and Information Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel coronavirus disease 2019 (COVID-19) outbreak has brought to light unprecedented challenges to global public health security. Researchers have devoted their efforts to in-depth research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to bring the epidemic under control as rapidly as possible. Among the many areas of burgeoning SARS-CoV-2 related research, various analytical technologies have been applied to the advancement of virus detection, and development of vaccines and innovative therapies. Separation technologies with the merits of simple operation, high separation efficiency, and high selectivity, have become widely used and are key to progress in life science, medicine, pharmaceutical discovery and development, and other fields. Separation technologies have played an irreplaceable role in the isolation, detection, diagnosis, treatment, and prevention of this novel coronavirus. In this review, an overview of the relevant literature is presented from ISI Web of Science spanning Jan. 1st, 2020-Dec. 31, 2020, using "SARS-CoV-2" or "COVID-19" as keywords. The top 20 research directions are summarized, based on papers published in high impact international journals (e. g.

Indexed as

CentrifugationChromatography, LiquidCOVID-19EpidemicsHumansMagneticsSARS-CoV-2Tandem Mass SpectrometryTechnologyaffinity chromatography (AC)centrifugationelectrophoresisliquid chromatography (LC)magnetic bead separationmicro/nano-separationseparation technologysevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)size exclusion chromatography (SEC)

Identifiers

PMID34227364
PMCPMC9421565
OpenAlexW3173641487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.